Connection

David Veyer to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications David Veyer has written about Antibodies, Viral.
David Veyer
Connection Strength
0.178
Antibodies, Viral
  1. Unexpected diagnosis of COVID-19-associated disorders by SARS-CoV-2-specific serology. J Clin Virol. 2020 11; 132:104568.
    View in: PubMed
    Score: 0.085
  2. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021 08; 596(7871):276-280.
    View in: PubMed
    Score: 0.023
  3. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat Med. 2021 05; 27(5):917-924.
    View in: PubMed
    Score: 0.022
  4. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel. J Med Virol. 2021 04; 93(4):2196-2203.
    View in: PubMed
    Score: 0.022
  5. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295.
    View in: PubMed
    Score: 0.022
  6. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests. J Virol Methods. 2021 04; 290:114067.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.